Translational Development Acquisition TDAC
NASDAQ TDAC
$10.85 +0.01 (+0.05%)
As of: Aug 21, 2026 · 3:58 PM EDT

Translational Development Acquisition (TDAC) Profit After Tax Growth (1y) (2025 - 2026)

Translational Development Acquisition (TDAC) Profit After Tax Growth (1y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (1y) (Qtr)
1 Oxley Bridge Acquisition 585.76 Mn 585.76 Mn - -
2 Launch Two Acquisition 557.86 Mn 557.86 Mn - -
3 Drugs Made In America Acquisition 507.00 Mn 507.00 Mn - -
4 Cantor Equity Partners IV 468.00 Mn 468.00 Mn - -
5 GP-Act III Acquisition 401.06 Mn 401.06 Mn - -
6 Aldel Financial 397.49 Mn 397.49 Mn - -
7 Republic Digital Acquisition 389.25 Mn 388.51 Mn - -
8 Gores Holdings X 385.06 Mn 384.87 Mn - 115.23%
9 Agriculture & Natural Solutions Acquisition 377.29 Mn 377.04 Mn - 2,394.57%
10 Translational Development Acquisition 182.66 Mn 182.57 Mn - -41.66%

Historic Data

Download Data
DateValue
Mar 31, 2026 -10.13%
Dec 31, 2025 19,939.50%
Sep 30, 2025 2,808.94%